IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bain Capital Life Sciences Investors, LLC

Q1 2019 Holdings

Filed 2019-05-15 | 6 holdings | $250.1K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Dicerna Pharmaceuticals Inc(DRNAUSD)COM253031108$130.8K8,930,23752.3%
Replimune Group Inc(REPL)COM76029N106$43.2K2,838,96817.3%
Inflarx NV(IFRX)COMN44821101$27.7K732,67011.1%
Marinus Pharmaceuticals IncCOM56854Q101$21.1K5,042,7358.4%
Solid Biosciences IncCOM83422E105$18.3K1,989,4447.3%
Aptinyx IncCOM03836N103$9.0K2,225,0923.6%